300497 富祥药业
已收盘 12-05 15:00:00
资讯
新帖
简况
富祥药业：产品通过下游客户进入宁德时代供应链
证券之星 · 12-04 20:48
富祥药业：产品通过下游客户进入宁德时代供应链
富祥药业：未冉蛋白获认证打开新成长空间
证券之星 · 12-04 11:33
富祥药业：未冉蛋白获认证打开新成长空间
富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的
证券之星 · 12-04 11:33
富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的
富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与
证券之星 · 12-01
富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与
富祥药业(300497.SZ)拟授出不超620万份股票期权
智通财经 · 11-27
富祥药业(300497.SZ)拟授出不超620万份股票期权
富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证
智通财经 · 11-27
富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证
富祥药业：VC、FEC产线稳健运行
证券之星 · 11-27
富祥药业：VC、FEC产线稳健运行
富祥药业(300497.SZ)通过巴西国家卫生监督局GMP认证
智通财经 · 11-26
富祥药业(300497.SZ)通过巴西国家卫生监督局GMP认证
富祥药业：VC产能将分阶段扩至20000吨/年
证券之星 · 11-18
富祥药业：VC产能将分阶段扩至20000吨/年
11月17日富祥药业（300497）龙虎榜数据：游资虹桥路徐晓上榜
证券之星 · 11-17
11月17日富祥药业（300497）龙虎榜数据：游资虹桥路徐晓上榜
富祥药业：公司计划通过技改等措施将VC产品产能增加至1万吨/年 预计2026年二季度改造完成
视频滚动新闻 · 11-16
富祥药业：公司计划通过技改等措施将VC产品产能增加至1万吨/年 预计2026年二季度改造完成
富祥药业：他唑巴坦、舒巴坦是公司主要医药产品
证券日报 · 11-14
富祥药业：他唑巴坦、舒巴坦是公司主要医药产品
富祥药业：公司VC和FEC产品的主要客户是天赐材料、新宙邦等
证券日报网 · 11-14
富祥药业：公司VC和FEC产品的主要客户是天赐材料、新宙邦等
11月14日富祥药业（300497）龙虎榜数据：北向资金净买入1406.21万元
证券之星 · 11-14
11月14日富祥药业（300497）龙虎榜数据：北向资金净买入1406.21万元
年内揽近70%涨幅！有机硅凭啥因“十五五”规划站上风口？
中金财经 · 11-14
年内揽近70%涨幅！有机硅凭啥因“十五五”规划站上风口？
“吃药”行情归来？4600亿巨头成功扭亏，港A创新药全线沸腾
格隆汇 · 11-13
“吃药”行情归来？4600亿巨头成功扭亏，港A创新药全线沸腾
富祥药业（300497）披露变更持续督导保荐代表人公告，11月12日股价上涨5.65%
证券之星 · 11-12
富祥药业（300497）披露变更持续督导保荐代表人公告，11月12日股价上涨5.65%
富祥药业：公司生产经营一切正常
证券之星 · 11-12
富祥药业：公司生产经营一切正常
富祥药业(300497.SZ)通过美国FDA现场检查
智通财经 · 11-06
富祥药业(300497.SZ)通过美国FDA现场检查
富祥药业：产品市场价格上涨对业绩增长具积极影响
证券之星 · 11-05
富祥药业：产品市场价格上涨对业绩增长具积极影响
加载更多
公司概况
公司名称：
江西富祥药业股份有限公司
所属行业：
医药制造业
上市日期：
2015-12-22
主营业务：
江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售，在技术同源的基础上，拓展化学合成与生物合成的应用领域，大力发展锂电池电解液添加剂业务和拓展合成生物学微生物蛋白业务。公司的主要产品是医药制造业、锂离子电池产业链相关业务、微生物蛋白业务。
发行价格：
15.33
{"stockData":{"symbol":"300497","market":"SZ","secType":"STK","nameCN":"富祥药业","latestPrice":14.7,"timestamp":1764918237000,"preClose":14.47,"halted":0,"volume":35013980,"delay":0,"changeRate":0.0159,"floatShares":441000000,"shares":539000000,"eps":-0.5065,"marketStatus":"已收盘","change":0.23,"latestTime":"12-05 15:00:00","open":14.41,"high":14.91,"low":14.28,"amount":513000000,"amplitude":0.0435,"askPrice":14.71,"askSize":137,"bidPrice":14.7,"bidSize":345,"shortable":0,"etf":0,"ttmEps":-0.5065,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.47,"symbolType":"stock","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":15.92,"lowLimit":13.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":538648934,"isCdr":false,"pbRate":3.63,"roa":"--","roe":"--","epsLYR":-0.51,"committee":-0.467692,"marketValue":7918000000,"turnoverRate":0.0794,"status":0,"floatMarketCap":6480000000},"requestUrl":"/m/hq/s/300497","defaultTab":"news","newsList":[{"id":"2588884862","title":"富祥药业：产品通过下游客户进入宁德时代供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884862?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:48","pubTimestamp":1764852514,"startTime":"0","endTime":"0","summary":"公司产品通过下游客户进入锂电池产业链，最终应用于包括宁德时代在内的锂电池生产商。关于具体的客户认证及供应关系，涉及公司与合作方的商业约定，公司依据信息披露相关规定履行披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2476274720.SGD","LU2039709279.SGD","LU0828237940.HKD","LU0516423091.SGD","IE0032431581.USD","LU0607220059.USD","LU1769817179.HKD","LU0049853897.USD","LU0359201885.HKD","LU0828237510.HKD","LU0124384867.USD","LU0051755006.USD","LU0531971595.HKD","LU2153591404.USD","LU2348774022.SGD","LU1769817096.USD","LU2097828631.EUR","300750","LU2152927971.USD","EVS.SI","LU0228659784.USD","LU1303224171.USD","LU0572944931.SGD","LU1152091754.HKD","LU1048596156.SGD","LU0143863198.USD","LU1813983027.USD","LU0543330483.HKD","LU3063872942.SGD","LU0054450605.USD","LU0106259558.USD","LU1146622755.USD","LU0348805143.USD","LU0132412106.USD","SG9999001689.USD","SG9999001846.SGD","LU1008478684.HKD","SG9999001903.USD","LU0327786744.USD","LU1721428347.USD","LU1997245177.USD","LU1251922891.USD","IE00B543WZ88.USD","LU2097828557.USD","LU0244354667.USD","BK0239","LU2506952253.HKD","300497","LU1979443071.USD","03750"],"gpt_icon":0},{"id":"2588072150","title":"富祥药业：未冉蛋白获认证打开新成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2588072150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588072150?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:33","pubTimestamp":1764819206,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业12月03日在投资者关系平台上答复投资者关心的问题。富祥药业回复：尊敬的投资者您好，截至目前公司已具备年产1200吨未冉蛋白的生产能力，并正在加速推进年产2万吨未冉蛋白项目建设。公司未冉蛋白已于近期正式通过国家卫健委新食品原料认证，标志着该产品获得了在国内市场生产销售的资格，其成功获批为公司打开了全新的成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400013193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0201","BK0239"],"gpt_icon":0},{"id":"2588507212","title":"富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的","url":"https://stock-news.laohu8.com/highlight/detail?id=2588507212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588507212?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:33","pubTimestamp":1764819201,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：据称公司外购亚硫酸乙烯酯es原料已经高达15万每吨，请问公司为什么不自己生产该原料富祥药业回复：尊敬的投资者您好，公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的，公司将持续评估产业链布局，以提升整体竞争力，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400013190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2588711292","title":"富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2588711292","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588711292?lang=zh_cn&edition=full","pubTime":"2025-12-01 09:08","pubTimestamp":1764551320,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月30日富祥药业发布公告称公司于2025年11月28日接受机构调研，山西证券、国元证券、九方智投、瑞奇期货、承风金萍基金、信迹投资、李蓬勃,胡晓俊参与。另外，富祥未冉蛋白已取得中国、美国、新加坡、欧洲等国家有关部门准入许可，为其全球化商业运用奠定了坚实基础。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","000728","BK0028","BK0012","BK0239","002500","BK0188","300497","BK0201","BK0183"],"gpt_icon":0},{"id":"2586242722","title":"富祥药业(300497.SZ)拟授出不超620万份股票期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2586242722","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586242722?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:49","pubTimestamp":1764244195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)披露第一期股票期权激励计划(草案)，公司拟向激励对象授予不超过620万份的股票期权(首次授予不超过505万份)，行权价格为16.15元/股。首次授予的激励对象不超过50人。本激励计划的有效期自股票期权首次授予之日起至激励对象获授的股票期权全部行权或注销之日止，最长不超过60个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","300497","BK0239"],"gpt_icon":0},{"id":"2586458472","title":"富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586458472","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586458472?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:13","pubTimestamp":1764234799,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)公告，国家卫生健康委员会(简称“国家卫健委”)近日发布了《关于威尼斯镰刀菌蛋白等14种“三新食品”的公告》，根据《食品安全法》规定，国家卫健委审评机构组织专家对威尼斯镰刀菌蛋白物质申请新食品原料的安全性评估材料进行审查并通过。该项公告的发布，标志着由公司子公司江西富祥生物科技有限公司(简称“富祥生物”)向国家卫健委提出的关于威尼斯镰刀菌蛋白新食品原料行政许可审批获得通过，富祥未冉蛋白将可作为新食品原料在国内进行生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300497","BK0201","BK0239"],"gpt_icon":0},{"id":"2586213823","title":"富祥药业：VC、FEC产线稳健运行","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213823?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:33","pubTimestamp":1764214389,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问公司VC产线目前正常吗？是否有对外销售，目前销售价格如何？富祥药业回复：尊敬的投资者您好，目前公司VC、FEC产线稳健运行，生产经营正常，依据客户订单有序交付。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700012434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0239","BK0201"],"gpt_icon":0},{"id":"2586232541","title":"富祥药业(300497.SZ)通过巴西国家卫生监督局GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586232541","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586232541?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:43","pubTimestamp":1764146632,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)公告，公司取得了由巴西国家卫生监督局(ANVISA)签发的药品生产质量管理规范(GMP)认证证书。认证范围为化学原料药：他唑巴坦。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"富祥药业(300497.SZ)通过巴西国家卫生监督局GMP认证","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300497","159100","BK0239","BK0201"],"gpt_icon":0},{"id":"2584876607","title":"富祥药业：VC产能将分阶段扩至20000吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2584876607","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584876607?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:33","pubTimestamp":1763436818,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业11月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2024年称vc产能8000吨每年，规划产能20000吨每年，请问20000吨的产线处于什么阶段？富祥药业回复：尊敬的投资者您好，公司目前具有8,000吨/年VC产品产能。公司计划通过技改等措施将VC产品产能增加至10,000吨/年，预计2026年二季度改造完成。后续将视市场需求及行业产能释放等情况，将VC产品产能增加至20,000吨/年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800014254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0239","BK0201"],"gpt_icon":0},{"id":"2584664692","title":"11月17日富祥药业（300497）龙虎榜数据：游资虹桥路徐晓上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2584664692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584664692?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:33","pubTimestamp":1763371987,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月17日公布的交易公开信息显示，富祥药业因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2025年11月17日收盘，富祥药业报收于21.15元，上涨12.14%，换手率42.8%，成交量188.67万手，成交额38.0亿元。虹桥路徐晓等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700023477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2583667304","title":"富祥药业：公司计划通过技改等措施将VC产品产能增加至1万吨/年 预计2026年二季度改造完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2583667304","media":"视频滚动新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583667304?lang=zh_cn&edition=full","pubTime":"2025-11-16 22:31","pubTimestamp":1763303460,"startTime":"0","endTime":"0","summary":"富祥药业(300497.SZ)发布投资者关系活动记录表，根据万得数据显示，近两年VC产品价格处于5万元/吨左右，而近期VC价格出现快速上涨，主要受储能电池、动力电池等需求快速增长以及宏观政策、行业供需变化等综合因素影响。公司目前具有8,000吨/年VC产品产能和约4000吨/年FEC产品产能。公司计划通过技改等措施将VC产品产能增加至10,000吨/年，预计2026年二季度改造完成。后续将视市场需求及行业产能释放等情况，将VC产品和FEC产品产能增加至20,000吨/年、5,000吨/年。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-11-16/doc-infxrmwu7156017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1815336091.USD","LU0757428866.USD","BK0201","300497","BK0239","IE00BZ199S13.USD","BK4124","VC"],"gpt_icon":0},{"id":"2583505330","title":"富祥药业：他唑巴坦、舒巴坦是公司主要医药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505330","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583505330?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:09","pubTimestamp":1763122140,"startTime":"0","endTime":"0","summary":"证券日报网讯富祥药业11月14日发布公告，在公司回答调研者提问时表示，他唑巴坦、舒巴坦是公司主要医药产品，2024年销售收入占公司营业收入40%左右。而6-apa是他唑巴坦、舒巴坦的主要原材料，根据万得数据显示，截至2025年11月3日，6-apa价格较2024年底下降38%。随着其价格下降，将有效提升公司医药制造业务毛利率。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpau4340288.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpau4340288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300497","BK0239","BK0201","BK1515","BK1161","09939","159938","BK1574"],"gpt_icon":0},{"id":"2583505998","title":"富祥药业：公司VC和FEC产品的主要客户是天赐材料、新宙邦等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505998","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583505998?lang=zh_cn&edition=full","pubTime":"2025-11-14 19:39","pubTimestamp":1763120340,"startTime":"0","endTime":"0","summary":"证券日报网讯富祥药业11月14日发布公告，在公司回答调研者提问时表示，公司目前已具有8，000吨/年VC产品产能和约4000吨/年FEC产品产能。计划通过技改等措施将VC产品产能增加至10，000吨/年，预计2026年二季度改造完成。后续将视市场需求及行业产能释放等情况，将VC产品和FEC产品产能增加至20，000吨/年、5，000吨/年。公司VC和FEC产品的主要客户是天赐材料、新宙邦等。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpat1514616.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpat1514616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0003","LU0029874905.USD","BK0076","LU0229945570.USD","LU1815336091.USD","BK4124","BK0077","300497","BK0229","IE00BZ199S13.USD","IE0005HP3H50.USD","LU0708995153.HKD","LU0320764243.SGD","BK0239","BK0132","LU0128522744.USD","LU0757428866.USD","300037","VC","BK0201","BK0028","002709","BK0155","LU0543330566.HKD"],"gpt_icon":0},{"id":"2583579028","title":"11月14日富祥药业（300497）龙虎榜数据：北向资金净买入1406.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579028","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579028?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112814,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，富祥药业因日换手率达到30%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月14日收盘，富祥药业报收于18.86元，上涨7.77%，换手率42.68%，成交量188.17万手，成交额35.93亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净买入1406.21万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300497","BK0239"],"gpt_icon":0},{"id":"2583652153","title":"年内揽近70%涨幅！有机硅凭啥因“十五五”规划站上风口？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583652153","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583652153?lang=zh_cn&edition=full","pubTime":"2025-11-14 14:10","pubTimestamp":1763100601,"startTime":"0","endTime":"0","summary":"“十五五”新能源建设提速，有机硅站上市场风口。据测算，至2030年，工业电气化、新能源汽车普及等因素将使全国电力需求较2025年增长40%。工信部原材料工业司相关负责人指出，“有机硅作为新能源产业链的关键配套材料，其需求增速将持续高于新能源产业整体增速”。业内人士认为，随着“十五五”新能源建设的加速推进，有机硅市场需求将持续攀升，行业发展前景广阔。板块年内累计涨幅达69.08%对于有机硅的行业前景，资本市场已率先做出反应。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202511/14/20251114628829.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202511/14/20251114628829.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251114/31796067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","BK0201","688353","300497","688602","300821","BK0239"],"gpt_icon":0},{"id":"2583853558","title":"“吃药”行情归来？4600亿巨头成功扭亏，港A创新药全线沸腾","url":"https://stock-news.laohu8.com/highlight/detail?id=2583853558","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583853558?lang=zh_cn&edition=full","pubTime":"2025-11-13 14:18","pubTimestamp":1763014725,"startTime":"0","endTime":"0","summary":"机构：中国创新药产业已进入2.0时代","market":"us","thumbnail":"https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f6068c36e82c4ed544af336a63a9d021","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3190454","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SG9999014674.SGD","300584","BK1515","688382","02268","01177","01672","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1589","06978","BK1141","BK1191","BK1521","BK1574","LU2488822045.USD","002864","IE00BZ08YS42.EUR","BK0201","BK1161","300497","BK0239"],"gpt_icon":1},{"id":"2582037215","title":"富祥药业（300497）披露变更持续督导保荐代表人公告，11月12日股价上涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582037215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582037215?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:02","pubTimestamp":1762956168,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，富祥药业报收于14.58元，较前一交易日上涨5.65%，最新总市值为78.54亿元。该股当日开盘13.89元，最高15.0元，最低13.21元，成交额达11.22亿元，换手率为17.93%。公司于近日发布公告称，江西富祥药业股份有限公司收到保荐机构长江证券承销保荐有限公司函件，因原持续督导保荐代表人王海涛先生工作调整，不再负责公司持续督导工作，长江保荐已委派章睿鹏先生接替其职务。变更后，公司持续督导保荐代表人为梁国超先生和章睿鹏先生。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300497","BK0201"],"gpt_icon":0},{"id":"2582328034","title":"富祥药业：公司生产经营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2582328034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582328034?lang=zh_cn&edition=full","pubTime":"2025-11-12 15:54","pubTimestamp":1762934065,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：近期听说公司生产出现事故爆炸，请问该消息是否属实？富祥药业回复：尊敬的投资者您好，公司生产经营一切正常，公司始终将安全生产放在首位，严格遵守各项规定，未发生重大安全生产事故。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200022110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0201","BK0239"],"gpt_icon":0},{"id":"2581567090","title":"富祥药业(300497.SZ)通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2581567090","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581567090?lang=zh_cn&edition=full","pubTime":"2025-11-06 15:53","pubTimestamp":1762415606,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业 发布公告，公司于2025年8月11日至2025年8月14日期间接受了美国食品药品监督管理局的cGMP现场检查。近日，公司收到了FDA签发的现场检查报告，此次检查以VAI的结果顺利通过。本次是公司第三次顺利通过FDA的cGMP现场检查，标志着公司质量体系接轨国际，具备持续为美国乃至全球市场提供商业化中间体和原料药的资质。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300497","BK0201"],"gpt_icon":0},{"id":"2581715702","title":"富祥药业：产品市场价格上涨对业绩增长具积极影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2581715702","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581715702?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:37","pubTimestamp":1762313838,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，现在（FEC）与（VC）价格上涨，请问会对公司四季度的业绩有积极影响吗？富祥药业回复：尊敬的投资者您好，产品市场价格上涨对于公司业绩增长具有积极影响，具体经营情况请以公司定期报告为准，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500014148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1764962400576,"stockEarnings":[{"period":"1week","weight":-0.0915},{"period":"1month","weight":0.3624},{"period":"3month","weight":0.3973},{"period":"6month","weight":0.5858},{"period":"1year","weight":0.4511},{"period":"ytd","weight":0.7626}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西富祥药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20651人(较上一季度减少7.87%)","perCapita":"21347股","listingDate":"2015-12-22","address":"江西省景德镇市昌江区鱼丽工业区2号(鱼山与丽阳交界处)","registeredCapital":"53864万元","survey":" 江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售，在技术同源的基础上，拓展化学合成与生物合成的应用领域，大力发展锂电池电解液添加剂业务和拓展合成生物学微生物蛋白业务。公司的主要产品是医药制造业、锂离子电池产业链相关业务、微生物蛋白业务。","listedPrice":15.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"富祥药业(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供富祥药业(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"富祥药业,300497,富祥药业股票,富祥药业股票老虎,富祥药业股票老虎国际,富祥药业行情,富祥药业股票行情,富祥药业股价,富祥药业股市,富祥药业股票价格,富祥药业股票交易,富祥药业股票购买,富祥药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"富祥药业(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供富祥药业(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}